$ATMV
AlphaVest Acquisition Corp.

2024 Q2 Form 10-K Financial Statement

#000149315224014881 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $147.4K $189.1K $676.3K
YoY Change 13.38% 145.42% 736.93%
Operating Profit -$147.4K -$676.3K
YoY Change 13.22%
Interest Expense $530.1K $987.9K $3.580M
YoY Change -36.13% 2483.99% 9265.66%
% of Operating Profit
Other Income/Expense, Net $530.1K $13.87K
YoY Change -36.49%
Pretax Income $382.8K $798.7K $2.904M
YoY Change -45.32% -2156.99% -6920.5%
Income Tax
% Of Pretax Income
Net Earnings $382.7K $798.7K $2.904M
YoY Change -45.68% -2156.99% -6920.51%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.05 $0.19 $0.41
COMMON SHARES
Basic Shares Outstanding 7.006M shares 9.181M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.79K $28.56K $28.56K
YoY Change -93.73% -95.67% -95.67%
Cash & Equivalents $13.79K $28.56K
Short-Term Investments
Other Short-Term Assets $55.95K $34.57K $34.57K
YoY Change 86.5% -58.23% -58.23%
Inventory
Prepaid Expenses $55.95K $34.57K
Receivables
Other Receivables
Total Short-Term Assets $69.74K $63.13K $63.13K
YoY Change -72.65% -91.49% -91.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $52.00M $50.88M $50.88M
YoY Change -27.84% -27.75% -27.75%
Other Assets $165.0K
YoY Change 450.0%
Total Long-Term Assets $52.16M $50.88M $50.88M
YoY Change -27.64% -27.78% -27.78%
TOTAL ASSETS
Total Short-Term Assets $69.74K $63.13K $63.13K
Total Long-Term Assets $52.16M $50.88M $50.88M
Total Assets $52.23M $50.94M $50.94M
YoY Change -27.8% -28.44% -28.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $386.5K $213.1K $213.1K
YoY Change 673.02% -14.07% -14.07%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $547.5K $165.0K $165.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $943.9K $388.0K $388.0K
YoY Change 1492.43% 50.45% 50.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $943.9K $388.0K $388.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $943.9K $380.0K $388.0K
YoY Change 1473.14% 47.34% 50.45%
SHAREHOLDERS EQUITY
Retained Earnings -$874.4K -$325.1K
YoY Change -483.72% 663.42%
Common Stock $228.00 $228.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$874.1K -$324.8K $50.56M
YoY Change
Total Liabilities & Shareholders Equity $52.23M $50.94M $50.94M
YoY Change -27.8% -28.44% -28.44%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $382.7K $798.7K $2.904M
YoY Change -45.68% -2156.99% -6920.51%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 -$30.48K -$630.5K
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$110.0K $23.12M $23.12M
YoY Change -132.85% -132.85%
Cash From Investing Activities -$110.0K $23.12M $23.12M
YoY Change -132.85% -132.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.0K -23.12M -$23.12M
YoY Change -132.54% -132.54%
NET CHANGE
Cash From Operating Activities 0.000 -30.48K -$630.5K
Cash From Investing Activities -110.0K 23.12M $23.12M
Cash From Financing Activities 110.0K -23.12M -$23.12M
Net Change In Cash 0.000 -30.48K -$630.5K
YoY Change -100.0% -104.62% -195.67%
FREE CASH FLOW
Cash From Operating Activities $0.00 -$30.48K -$630.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
ATMV Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023 ATMV Proceeds From Overallotment And Private Placement Net Of Underwriters Discount
ProceedsFromOverallotmentAndPrivatePlacementNetOfUnderwritersDiscount
usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
ATMV Payment For Redemption Of Ordinary Shares
PaymentForRedemptionOfOrdinaryShares
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023 ATMV Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
420 Lexington Ave
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2446
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10170
CY2023 dei City Area Code
CityAreaCode
203
CY2023 dei Local Phone Number
LocalPhoneNumber
998-5540
CY2023 ATMV Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption
23282936 usd
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
165000 usd
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
72312000 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7006329 shares
CY2023 dei Auditor Firm
AuditorFirmId
1195
CY2023 dei Auditor Name
AuditorName
UHY LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023Q4 us-gaap Cash
Cash
28560 usd
CY2022Q4 us-gaap Cash
Cash
659035 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34573 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
82771 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
63133 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
741806 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
32380 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
50880604 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
70418228 usd
CY2023Q4 us-gaap Assets
Assets
50943737 usd
CY2022Q4 us-gaap Assets
Assets
71192414 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213118 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
248034 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9837 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9837 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
165000 usd
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.77
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
596893 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-676318 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
3580311 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
38228 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
181 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3580492 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38228 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2904174 usd
us-gaap Net Income Loss
NetIncomeLoss
-42578 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1750 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3900000 usd
ATMV Stock Issued During Period Value Private Units
StockIssuedDuringPeriodValuePrivateUnits
405000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3734629 usd
us-gaap Net Income Loss
NetIncomeLoss
-42578 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
554543 usd
CY2023 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-3618539 usd
CY2023 ATMV Stock Issued During Period Value For Common Stock Subject To Redemption Amount Extension Deposit
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionAmountExtensionDeposit
-165000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2904174 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-324822 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-324822 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
2904174 usd
us-gaap Net Income Loss
NetIncomeLoss
-42578 usd
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3580311 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
38228 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80578 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
115152 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34916 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
161121 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
34837 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-630475 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
70380000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23117936 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70380000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1750 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
58500000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3900000 usd
ATMV Proceeds From Overallotment And Private Placement Net Of Underwriters Discount
ProceedsFromOverallotmentAndPrivatePlacementNetOfUnderwritersDiscount
9180000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
542715 usd
CY2023 ATMV Payment For Redemption Of Ordinary Shares
PaymentForRedemptionOfOrdinaryShares
23282936 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
165000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23117936 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71039035 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-630475 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
659035 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
659035 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28560 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
659035 usd
CY2023 us-gaap Stock Issued1
StockIssued1
3580311 usd
us-gaap Stock Issued1
StockIssued1
38228 usd
ATMV Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Common Stock
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfCommonStock
25000 usd
CY2022Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
61200000 usd
CY2022Q4 ATMV Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.20
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-3734629 usd
CY2023 ATMV Underwriting Expenses
UnderwritingExpenses
1725000 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
629929 usd
CY2023Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1425000 usd
CY2023 ATMV Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1 pure
CY2023Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000 usd
CY2023Q4 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
2174171 shares
CY2023Q4 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
23282936 usd
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.71
CY2024Q1 us-gaap Payments For Deposits
PaymentsForDeposits
55000 usd
CY2023Q4 us-gaap Cash
Cash
28560 usd
CY2023Q4 ATMV Working Capital
WorkingCapital
324822 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zilhmY3Bqpkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zqFVtj2FbXe9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28560 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
659035 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
50880604 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
70418228 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
3580311 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
38228 usd
CY2023Q4 ATMV Offering Costs
OfferingCosts
3734630 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zH02tdY1qV05" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zbdCPE2Ljgb3">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z6cA6O4YkqJl" title="Federal Depository Insurance Coverage">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023 ATMV Cash To Operating Account
CashToOperatingAccount
-657285 usd
CY2023 ATMV Underwriting Expenses
UnderwritingExpenses
1725000 usd
CY2023 ATMV Other Offering Expenses
OtherOfferingExpenses
-263675 usd
CY2023 ATMV Amount Held Back For Sponsor Portion Of Risk Capital
AmountHeldBackForSponsorPortionOfRiskCapital
-279040 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
70380000 usd
CY2023 ATMV Stock Issued During Period Value For Withdrawn In Connection With Redemption
StockIssuedDuringPeriodValueForWithdrawnInConnectionWithRedemption
-23282936 usd
CY2023 ATMV Stock Issued During Period Value For Common Stock Subject To Redemptions Amount Investment Held In Trust Account
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionsAmountInvestmentHeldInTrustAccount
3618540 usd
CY2023 ATMV Stock Issued During Period Value For Common Stock Subject To Redemptions Amount Extension Deposit
StockIssuedDuringPeriodValueForCommonStockSubjectToRedemptionsAmountExtensionDeposit
165000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
50880604 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
120000 usd
CY2023 us-gaap Other Expenses
OtherExpenses
13871 usd
us-gaap Professional Fees
ProfessionalFees
3871 usd
CY2022Q2 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
150000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
400000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
784 usd
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
784 usd
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
0 usd
CY2022Q4 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1725000 usd
CY2023 ATMV Percentage Of Cash Fee On Consideration Payable In Initial Business Combination
PercentageOfCashFeeOnConsiderationPayableInInitialBusinessCombination
0.010 pure
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2280500 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2280500 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4725829 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares

Files In Submission

Name View Source Status
0001493152-24-014881-index-headers.html Edgar Link pending
0001493152-24-014881-index.html Edgar Link pending
0001493152-24-014881.txt Edgar Link pending
0001493152-24-014881-xbrl.zip Edgar Link pending
atmv-20231231.xsd Edgar Link pending
ex10-18.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
atmv-20231231_def.xml Edgar Link unprocessable
atmv-20231231_cal.xml Edgar Link unprocessable
atmv-20231231_pre.xml Edgar Link unprocessable
atmv-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending